Phase 2 Coeliac Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your body mass index (BMI) must be between 18 and 40 at the time of your screening appointment.
- You must be willing to eat a gluten-free product and specially prepared products that simulate accidental gluten exposure as part of the study.
- You must have been formally diagnosed with celiac disease by a doctor, with that diagnosis recorded in your medical records.
- You must have been following a gluten-free diet for at least 12 months before your screening appointment, and must be willing to continue that same diet throughout the study.
- A blood test must confirm that you carry a specific genetic marker called HLA DQ2.5 (confirm with trial site).
- You must have experienced at least 2 gluten-related symptom episodes in the month before screening — these symptoms include diarrhea, stomach pain, bloating, nausea, or tiredness.
- You must be willing to have 2 internal camera examinations of your upper digestive tract (called endoscopies), which include taking small tissue samples from your small intestine.
- A tissue sample must show that there is still ongoing damage to the lining of your small intestine (confirm with trial site).
Who may not be able to join:
- You may not be eligible if you have been diagnosed with, or are suspected to have, a more severe form of celiac disease called Refractory Celiac Disease.
- You may not be eligible if you have a history of allergic reactions triggered by wheat, barley, rye, or certain ingredients used in the study products such as methylcellulose or gelatin.
- You may not be eligible if you have been diagnosed with cancer, including blood cancers or solid tumours, within the past 5 years, or if you have ever been diagnosed with T cell or B cell lymphoma.
- You may not be eligible if you have had a serious allergic reaction (including anaphylaxis) to a biological medicine or any of its ingredients.
- You may not be eligible if your genetic test shows you carry a different genetic marker called HLA-DQ8 (confirm with trial site).
- You may not be eligible if you have any other ongoing digestive condition — such as inflammatory bowel disease, irritable bowel syndrome, or acid reflux — that could affect the study results.
- You may not be eligible if tests show you currently have a stomach infection called Helicobacter pylori.
- You may not be eligible if your screening blood test is positive for HIV.
- You may not be eligible if your screening blood test shows signs of a current hepatitis B infection.
- You may not be eligible if your screening blood test is positive for hepatitis C, unless a follow-up test confirms the virus is not active in your body.
- You may not be eligible if a specific test shows you have active tuberculosis (TB) at the time of screening.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chugai Pharmaceutical Co., Ltd., clinical-trials@chugai-pharm.co.jp
Phone: only use Email
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
5 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Change in Villous Height to Crypt Depth Ratio (Vh:Cd)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.